Immunophenotypic analysis of adult patients with T-cell lymphoblastic lymphoma treated with hyper-CVAD

References

• Bell JJ, Bhandoola A. The earliest thymic progenitors for T cells possess myeloid lineage potential. Nature. 2008;452:764–767. doi: 10.1038/nature06840
   PubMed Web of Science ®Google Scholar
• Burkhardt B. Paediatric lymphoblastic T-cell leukaemia and lymphoma: one or two diseases? Br J Haematol. 2010;149:653–668. doi: 10.1111/j.1365-2141.2009.08006.x
   PubMed Web of Science ®Google Scholar
• Coustan-Smith E, Mullighan CG, Onciu M, et al. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol. 2009;10:147–156. doi: 10.1016/S1470-2045(08)70314-0
   PubMed Web of Science ®Google Scholar
• Thomas DA, O’Brien S, Cortes J, et al. Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma. Blood. 2004;104:1624–1630. doi: 10.1182/blood-2003-12-4428
   PubMed Web of Science ®Google Scholar
• Kato H, Yamamoto K, Oki Y, et al. Clinical value of flow cytometric immunophenotypic analysis for minimal residual disease detection in autologous stem-cell products of follicular and mantle cell lymphomas. Leukemia. 2012;26:166–169. doi: 10.1038/leu.2011.183
   PubMed Web of Science ®Google Scholar
• Hirano D, Kato H, Kodaira T, et al. Salvage therapy with single agent L-asparaginase followed by local irradiation in an elderly patient with CD56-positve primary isolated extramedullary T-cell lymphoblastic lymphoma of the sinus. Ann Hematol. 2015;94:173–175. doi: 10.1007/s00277-014-2128-7
   PubMed Web of Science ®Google Scholar
• Patel JL, Smith LM, Anderson J, et al. The immunophenotype of T-lymphoblastic lymphoma in children and adolescents: a Children’s Oncology Group report. Br J Haematol. 2012;159:454–461. doi: 10.1111/bjh.12042
   PubMed Web of Science ®Google Scholar
• Reiter A, Schrappe M, Ludwig WD, et al. Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood. 2000;95:416–421.
   PubMed Web of Science ®Google Scholar
• van Grotel M, Meijerink JP, van Wering ER, et al. Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences. Leukemia. 2008;22:124–131. doi: 10.1038/sj.leu.2404957
   PubMed Web of Science ®Google Scholar
• Kobayashi R, Takimoto T, Nakazawa A, et al. Inferior outcomes of stage III T lymphoblastic lymphoma relative to stage IV lymphoma and T-acute lymphoblastic leukemia: long-term comparison of outcomes in the JACLS NHL T-98 and ALL T-97 protocols. Int J Hematol. 2014;99:743–749. doi: 10.1007/s12185-014-1585-z
   PubMed Web of Science ®Google Scholar
• Inukai T, Kiyokawa N, Campana D, et al. Clinical significance of early T-cell precursor acute lymphoblastic leukaemia: results of the Tokyo Children’s Cancer Study Group Study L99-15. Br J Haematol. 2012;156:358–365. doi: 10.1111/j.1365-2141.2011.08955.x
   PubMed Web of Science ®Google Scholar
• Patrick K, Wade R, Goulden N, et al. Outcome for children and young people with early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003. Br J Haematol. 2014;166:421–424. doi: 10.1111/bjh.12882
   PubMed Web of Science ®Google Scholar
• Madanat F, Jaber H, Azayyat I, et al. Features and outcomes of pediatric early T cell leukemia: King Hussein Cancer Center experience. Hematol Oncol Stem Cell Ther. 2016;9:126–128. doi: 10.1016/j.hemonc.2015.09.001
   PubMedGoogle Scholar
• Vitale A, Guarini A, Ariola C, et al. Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol. Blood. 2006;107:473–479. doi: 10.1182/blood-2005-04-1754
   PubMed Web of Science ®Google Scholar
• Neumann M, Heesch S, Gokbuget N, et al. Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations. Blood Cancer J. 2012;2:e55. doi: 10.1038/bcj.2011.49
   PubMed Web of Science ®Google Scholar
• Van Vlierberghe P, Ambesi-Impiombato A, De Keersmaecker K, et al. Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia. Blood. 2013;122:74–82. doi: 10.1182/blood-2013-03-491092
   PubMed Web of Science ®Google Scholar
• Allen A, Sireci A, Colovai A, et al. Early T-cell precursor leukemia/lymphoma in adults and children. Leuk Res. 2013;37:1027–1034. doi: 10.1016/j.leukres.2013.06.010
   PubMed Web of Science ®Google Scholar
• Shimizu H, Handa H, Hatsumi N, et al. Distinctive disease subgroups according to differentiation stages in adult patients with T-cell acute lymphoblastic leukemia. Eur J Haematol. 2013;90:301–307. doi: 10.1111/ejh.12088
   PubMed Web of Science ®Google Scholar
• Chopra A, Bakhshi S, Pramanik SK, et al. Immunophenotypic analysis of T-acute lymphoblastic leukemia. A CD5-based ETP-ALL perspective of non-ETP T-ALL. Eur J Haematol. 2014;92:211–218. doi: 10.1111/ejh.12238
   PubMed Web of Science ®Google Scholar
• Jain N, Lamb AV, O’Brien S, et al. Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype. Blood. 2016;127:1863–1869. doi: 10.1182/blood-2015-08-661702
   PubMed Web of Science ®Google Scholar
• Brammer JE, Saliba RM, Jorgensen JL, et al. Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomes. Bone Marrow Transplant. 2017;52:20–27. doi: 10.1038/bmt.2016.194
   PubMed Web of Science ®Google Scholar
• Guo RJ, Bahmanyar M, Minden MD, et al. CD33, not early precursor T-cell phenotype, is associated with adverse outcome in adult T-cell acute lymphoblastic leukaemia. Br J Haematol. 2015;172:823–825. doi: 10.1111/bjh.13545
   PubMed Web of Science ®Google Scholar
• Zhang J, Ding L, Holmfeldt L, et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature. 2012;481:157–163. doi: 10.1038/nature10725
   PubMed Web of Science ®Google Scholar